Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
А. И. Макарков(McGill University Health Centre), Brian J. Ward(McGill University Health Centre)
Cited by 42
Related Papers
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
|Cellular and Molecular Immunology|2022|59
Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity
|npj Vaccines|2022|16
Influenza vaccine development: immunogenicity and correlates of protection
|eScholarship@McGill (McGill)|2019|1